• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

N-(2-Bromoethyl)-4-fluorobenzenesulfonamide (CAS 51983-24-5): A Comprehensive Guide

N-(2-Bromoethyl)-4-fluorobenzenesulfonamide (CAS 51983-24-5) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This sulfonamide derivative, characterized by its 2-bromoethyl and 4-fluorobenzenesulfonamide functional groups, serves as a versatile intermediate in synthetic chemistry. Its unique structure makes it valuable for designing novel molecules, particularly in drug discovery and material science applications.

The compound's molecular formula is C₈H₉BrFNO₂S, with a molecular weight of 282.13 g/mol. Researchers often explore N-(2-Bromoethyl)-4-fluorobenzenesulfonamide for its potential in creating biologically active compounds, thanks to the reactivity of its bromoethyl group and the stability imparted by the fluorobenzenesulfonamide moiety. Recent studies highlight its role in developing enzyme inhibitors and receptor modulators, aligning with current trends in precision medicine and targeted therapy.

One of the most searched questions about CAS 51983-24-5 relates to its synthetic applications. This compound is frequently employed in cross-coupling reactions and nucleophilic substitutions, making it a staple in laboratories focused on medicinal chemistry. Its compatibility with palladium-catalyzed reactions, such as Suzuki-Miyaura couplings, has been particularly noted in peer-reviewed journals. These properties position it as a critical building block for high-value pharmaceuticals, including potential treatments for neurological and inflammatory conditions.

From an industrial perspective, the demand for N-(2-Bromoethyl)-4-fluorobenzenesulfonamide has risen due to its utility in API (Active Pharmaceutical Ingredient) synthesis. Manufacturers emphasize its high purity (>98%) and consistent batch-to-batch reproducibility, which are crucial for regulatory compliance in drug development. The compound's stability under various storage conditions (recommended at 2-8°C) further enhances its practicality for large-scale applications.

Environmental and safety considerations for 51983-24-5 follow standard laboratory protocols for sulfonamide derivatives. While not classified as hazardous under current regulations, proper handling with PPE (personal protective equipment) is advised due to its bromoethyl component. This aligns with the growing industry focus on green chemistry principles and sustainable synthetic routes, a hot topic in 2024 chemical research.

Analytical characterization of N-(2-Bromoethyl)-4-fluorobenzenesulfonamide typically involves HPLC, NMR (1H and 13C), and mass spectrometry techniques. Recent advancements in AI-assisted molecular analysis have enabled faster identification of its spectral signatures, addressing another common search query about compound verification methods. These technological integrations reflect the evolving landscape of chemical research where digital tools enhance traditional laboratory workflows.

The global market for fluorinated sulfonamides like CAS 51983-24-5 shows steady growth, driven by pharmaceutical R&D investments. Patent analyses reveal increasing references to this compound in applications ranging from kinase inhibitors to PET radiotracer development. Such diverse applications make it a recurring subject in scientific literature searches, particularly among researchers exploring structure-activity relationships in drug design.

For procurement specialists, key considerations include supplier reliability and documentation (e.g., Certificate of Analysis). The compound's availability through major chemical distributors ensures accessibility for academic and industrial researchers worldwide. Current pricing trends reflect its status as a research-grade chemical, with costs varying based on quantity and purity specifications.

Future research directions for N-(2-Bromoethyl)-4-fluorobenzenesulfonamide may explore its potential in bioconjugation chemistry or as a precursor for fluorescent probes. These applications align with emerging interests in theranostics (combined therapy and diagnostics) – a rapidly growing field that frequently appears in recent scientific search trends. Such developments underscore the compound's enduring relevance in cutting-edge chemical research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)